Is there a benefit to early bDMARD? In psoriatic arthritis (PsA) EULAR – The European Alliance of Associations for Rheumatology – recommends a treat-to-target approach, and suggests more intensive therapy for people with poor prognostic factors, depending on the disease presentation.